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Trypanosoma cruzi, the protozoan responsible for Chagas disease, has a complex life cycle comprehending two distinct hosts and a
seriesofmorphologicalandfunctionaltransformations.Hemoglobindegradationinsidetheinsectvectorreleaseshighamountsof
heme, and this molecule is known to exert a number of physiological functions. Moreover, the absence of its complete biosynthetic
pathway in T. cruzi indicates heme as an essential molecule for this trypanosomatid survival. Within the hosts, T. cruzi has to cope
with sudden environmental changes especially in the redox status and heme is able to increase the basal production of reactive
oxygen species (ROS) which can be also produced as byproducts of the parasite aerobic metabolism. In this regard, ROS sensing
is likely to be an important mechanism for the adaptation and interaction of these organisms with their hosts. In this paper we
discuss the main features of heme and ROS susceptibility in T. cruzi biology.
1.Trypanosoma cruzi andIts Biological Cycle
Trypanosoma cruzi comprises a complex group of parasite
populations circulating among humans, vectors, reservoirs,
and wild and domestic animals [1]. This parasite is the
causative agent of Chagas disease or American trypanosomi-
asis [2] and is transmitted through triatomine vectors, which
are blood-sucking insects, when they feed on the vertebrate
host.
After an insect feeds on the blood of an infected
vertebrate,thedevelopmentcycleoftheparasitebeginsinthe
intestinal tract of triatomines. In the anterior midgut, most
blood trypomastigotes transform into epimastigotes a few
hours after ingestion. Some epimastigotes multiply by lon-
gitudinal binary ﬁssion, and in the insect rectum, a new dif-
ferentiation occurs (metacyclogenesis process) in which epi-
mastigotes are transformed into metacyclic trypomastigotes.
These metacyclic trypomastigotes (highly infectious) are
shed in feces and reach the bloodstream of a new vertebrate
host after this host scratches an insect bite. The organisms
penetrate the mucosa where there are many macrophages;
after intense multiplication in the host cell in the form
of amastigotes, they transform into trypomastigotes again,
returning to the vertebrate circulation and completing the
cycle [3]. These series of morphological and biochemical
transformations in the life cycle may occur in response
to external stimuli [4]. Recently, reactive oxygen species
(ROS) and heme have been hypothesized to be important
signaling molecules. In this way, protozoan parasites, which
are speciﬁcally located in places where these molecules are
constantly released, must evolve special mechanisms to take
advantage of them. This paper will focus on the principal
features of heme in T. cruzi biology and how diﬀerent forms
of these parasites are susceptible to ROS.2 Journal of Parasitology Research
2. VectorsofTrypanosoma cruzi
2.1. Biting Patterns and Importance of the Heme Molecule.
Both the Rhodnius prolixus and Triatoma infestans species
are very important in disease transmission. Diﬀerentiation
into each of the ﬁve larval stages and the adult stage of
these organisms is determined by their food. These blood-
sucking insects ingest 6 to 12 times their original weight
in blood. Usually, approximately 10mM of heme bound to
hemoglobin is obtained in a single ingestion [5].
Heme is a ubiquitous molecule usually associated with
polypeptide chains through interactions between the iron
atom and histidine or methionine residues. Heme catalyzes
many oxidation processes in biological systems and is very
important in cellular functions, as it is involved in oxygen
transport (hemoglobin and myoglobin), in cellular respira-
tion (cytochromes), in antioxidant defenses (peroxidases),
in drug detoxiﬁcation enzyme (P450), and cell signalling
regulation(nitricoxidesynthase)[6,7].Therefore,hemeand
hemeproteins are involved in basic functions such as oxygen
sensitivity,cellularrespiration,metabolism,growth,renewal,
andcelldiﬀerentiation,whichareallessentialforthesurvival
of organisms. Moreover, heme is a toxic molecule due to its
abilitytogeneratereactiveoxygenspeciesanditsamphiphilic
features, to associate with lipid membranes, leading to
altered membrane permeabilization and cell disruption [8–
11].
2.2. Heme Uptake by T. cruzi Epimastigotes. The literature
reports that there are some organisms that depend on
essential hemeproteins but lack a heme biosynthetic pathway
in part or in total; trypanosomatids are included in this
group [12, 13]. In fact, biochemical and genomic studies
have demonstrated the absence of key enzymes of heme
biosynthesis in T. cruzi [14, 15]. In this regard, it is plausible
that these parasites take up heme from the midgut of their
vector.
In fact, during the development of T. cruzi epimastigotes
in the digestive tract of insects, parasites utilize exogenous
growth factors. Using ultrastructural studies, it has been
noted that these factors are taken up by endocytosis via
the ﬂagellar pocket and the cytostome [16]. The cytostome,
present in the anterior region of the cell near the ﬂagellar
pocket, is the preferred site of entry of bovine albumin
and transferrin, and are reservosomes, the mature form of
endosomes [17].
Interestingly, internalization of heme and hemoglobin
proceeds through diﬀerent routes and/or mechanisms. It
has been shown through ﬂuorescence microscopy using
ﬂuorescent heme analogues that entry is not modiﬁed by
lowering the temperature, by preincubation with unlabeled
hemoglobin or by reduction of ATP production. On the
other hand, the transport of heme is compromised by
the addition of cyclosporine, an inhibitor of ATP Binding
Cassette- (ABC-) type transporters. This is the ﬁrst evidence
that heme uptake involves the activity of a P-glycoprotein
(Pgp) homologue, an ABC transporter [18]. It has also
been inferred that other insect trypanosomatids including
Crithidia deanei, Crithidia oncopelti, and Blastocrithidia
culicis obtain haem from their bacterial endosymbionts [19].
2.3.TheIntracellularTraﬃckingofHemeinT.cruziEpimastig-
otes. Although ﬂuorescent analogue of heme is internalized
fasterthanhemoglobininT.cruzi,suggestingtheexistenceof
two diﬀerent pathways used to target molecules, the intracel-
lular traﬃc of heme is the same as other various molecules,
including several proteins [18, 20]. Heme internalization
startsatthecytostome,involvingvesiclesthattravelalongthe
cell body (early endosomes), and ends at the reservosomes,
which have been described as a site for protein and lipid
accumulation [18].
2.4. Hemeas a Signaling Moleculein T. cruzi Proliferation.
Malaquias and Oliveira [21] showed that, when exposed
to mitogenic factors present in fetal serum, T. cruzi cells
arestimulated byphosphoinositide-speciﬁc phospholipase C
(PI-PLC), leading to the accumulation of phosphatidylinosi-
tol 3-phosphate (IP3) and diacylglycerol (DAG) and increas-
ing their proliferation. Recent studies have shown the impor-
tance of second messengers in diﬀerentiation of trypanoso-
matids, including T. brucei-induced cAMP (adenosine 3 -
5  cyclic monophosphate) [22]. Several serine/threonine
kinases, including a cyclin-dependent kinases [23]a n d
a cAMP-dependent protein kinase (PKA) [24], phos-
phatidylinositol 3-kinase [25], a calcium-dependent pro-
tein kinase (PKC) [26], and a kinase dependent on calcium/
calmodulin [27], have been identiﬁed in T. cruzi epimastig-
otesthroughbiochemicalstudies,andinsomecases,through
molecular studies as well, such as PKA [28, 29]. The iden-
tiﬁcation of these kinases groups has been corroborated by
P a r s o n se ta l .[ 30]. Also in T. cruzi, before the diﬀerentiation
of epimastigotes into metacyclic trypomastigotes, cAMP
levels increase three- to fourfold inducing the diﬀerentiation
of T. cruzi epimastigotes to metacyclic trypomastigotes [31].
It has been shown that heme, but not hemoglobin or
its peptides, stimulates T. cruzi proliferation in vitro in a
dose-dependent manner. Diﬀerent strains were tested (Y and
Dm28c), and both increased in the same manner. Further, a
wide heme concentration range was employed, and even at
higher concentrations, cells proliferated following the heme
addition [18]. The authors hypothesized that heme could
drive T. cruzi proliferation through a kinase cascade.
Heme-induced growth of epimastigotes is not aﬀectedby
inhibitors of cGMP-dependent protein kinase (PKG), PKC,
PKA, PI3K, or cyclin-dependent kinase. Moreover addition
of KN 93 and Myr-AIP (inhibitors of calmodulin kinase) to a
culture of these cells reduces the expected growth, indicating
the involvement of calmodulin kinase in heme-mediated cell
signaling [32]. Furthermore, the authors showed that heme-
induced T. cruzi growth is associated with CaMKII [31],
demonstrating a signaling role for the heme molecule in
the biological cycle of Trypanosoma cruzi. Recently, heme
was shown to modulate a (Na+ +K +)A T P a s e ,v i ah e m e
receptor-mediated stimulation of the PI-PLC/PKC signaling
pathway in Leishmania amazonensis [33]. On the other
hand, in Trypanosoma brucei brucei this biomolecule mayJournal of Parasitology Research 3
be involved in nutritional control; it was able to inhibit
activity of ectonucleoside triphosphate diphosphohydrolases
(E-NTPDases), an enzyme that is involved in the generation
of free adenosine outside of the cell, together with ecto-5 -
nucleotidase [34].
2.5. Redox Metabolism of T. cruzi. As a protozoan parasite
of vertebrate and invertebrate hosts, T. cruzi is susceptible
to a number of oxidative killing mechanisms, including
reactive oxygen species (ROS). ROS can be produced during
the degradation of hemoglobin in the midgut of insect
vector as a consequence of the release of high amounts
of heme or as a byproduct of T. cruzi aerobic metabolism
[5, 35]. During respiration, molecular oxygen can undergo
partial reduction, giving rise to relatively stable species, by
accepting one, two, or three electrons, with the formation
of superoxide anions O
•−
2 ,h y d r o g e np e r o x i d e( H 2O2), and
hydroxyl radicals (•OH), respectively [36]. High rates of
O
•−
2 can also be produced by the NADPH oxidase complex,
which becomes active immediately after phagocytosis by
macrophages. Superoxide radicals can also generate the
formation of H2O2 by spontaneous or SOD-catalyzed dis-
mutation [37].
ThemitochondriaarethemainsourceofROSgeneration
in most eukaryotic cells. Mitochondrial ROS are recognized
as the key element in cell signaling processes and in a variety
of degenerative mechanisms [38]. The Trypanosomatidae
family is characterized by a single long mitochondrion
with a dilated region known as the kinetoplast, in which
mitochondrial DNA (kDNA) is observed [39]. Despite these
peculiar characteristics, mitochondria of trypanosomatids
are able to generate and sustain a membrane potential
comparable to mammalian mitochondria [40].
Like other trypanosomatids, T. cruzi has an intricate
antioxidant defense system that varies with their life stages
and is distinct from its mammal host and insect vector in
its complexity. In contrast to their hosts, trypanosomatids
lack GSH/glutathione reductase (GR) and thioredoxin/
thioredoxin reductase systems. Their redox metabolism
depends on a particular dithiol called trypanothione and its
corresponding reductase, trypanothione reductase (TryR).
Moreover, T. cruzi lacks catalase and glutathione peroxidase
(GPx), two major eukaryotic enzymes employed in the
detoxiﬁcation of peroxides. In spite of the absence of these
two enzymes, T. cruzi possesses two peroxiredoxins, an
ascorbate-dependent hemoperoxidase, several distinct per-
oxidases, of which at least two share sequence homology
with GPx, and four iron-containing superoxide dismutases
(SOD). For a complete review of redox metabolism in T.
cruzi,s e e[ 41]. A controlled balance between extracellular
ROS production and the ability of the cell to deal with these
oxidants may predict the success of certain life stages in
colonization and survival within the host.
3. Differential Susceptibilityof
T. cruzi Life Stages to ROS
T. cruzi responds diﬀerently to oxidative stress depending on
itslifestage.Analysisof10strainsfromT.cruzidemonstrated
a signiﬁcant increase in trypanothione synthetase (TryS)
and in cytosolic and mitochondrial tryparedoxin peroxidase
isoforms, during diﬀerentiation from the noninfective epi-
mastigote to the infective metacyclic trypomastigote form.
Moreover, these elevations in antioxidant enzymes were
shown to be more pronounced in the virulent strains than in
attenuated ones [42]. At the same time, ascorbate peroxidase
andTryRremainedunchangedduringthediﬀerentlifestages
of the parasite [42].
Thesediﬀerencesinsensitivitycorrelatedwiththegenetic
diversity between the lineages T. cruzi. A comparative study
between two diﬀerent strains of T. cruzi, the Tulahuen strain
(T. cruzi VI [43], previously classiﬁed as T. cruzi I) and
the Y strain (T. cruzi II), showed signiﬁcant diﬀerences in
the resistance to H2O2 treatment. Epimastigote forms of
Tulahuen strain were shown to be more resistant to H2O2
than Y strain, presenting higher activity of glucose-6-
phosphate dehydrogenase (G6PDH), an enzyme implicated
in the supply of NADPH, due to proper function of the
trypanothione-dependent system and an increase in the
cytosolic tryparedoxin peroxidase (TcCPx) content [35, 44].
Interestingly, Tulahuen strain was shown to be more suscep-
tible to benznidazole, a well known prooxidant trypanocidal
drug, than Y strain [45, 46]. In agreement with these
ﬁndings, the T. cruzi I strains Col1.7G2 and Silvio X-10 cl1
displayedmoreresistancetoH2O2 treatmentthantheT.cruzi
II strains JG and Esmeraldo cl3. Nevertheless, in contrast to
the phenotypes observed with the Y and Tulahuen strains,
these diﬀerences could not be attributed to diﬀerences in the
redox potential of the strains analyzed [47]. In this case, the
diﬀerential sensitivity to oxidative stress was suggested to be
due to changes in the activity of MSH2, a central component
of the DNA mutation and mismatch repair (MMR) machin-
ery [47]. The MMR has a key function in recognizing
and repairing base mismatches and frame shift mismatches
that escape DNA polymerase proofreading during DNA
replication [48].
With respect to life stage, T. cruzi epimastigotes seem
to be more susceptible to the generation of H2O2 resulting
from xanthine oxidase activity in the serum of chagasic
patients lacking a complement system. The treatment of
epimastigoteswiththisserumresultedinaninhibitionofcell
growthin vitro, a decreasein SODactivity, and anincrease in
membrane lipid peroxidation. Interestingly, the same results
were not observed when parasites were treated with serum
from healthy individuals [49]. Why epimastigotes have
higher susceptibility to human serum than infective forms is
unclear, but the exposure of epimastigotes to fresh human
serum over a short period of time led to a decrease in
cell respiration, loss of mitochondrial membrane potential,
increased O
•−
2 production, and release of cytochrome c,
a process characteristic of programmed cell death [50].
Moreover, it seems that the mitochondrion has a fundamen-
tal role in epimastigote-dependent complement activation;
an accumulation of high amounts of Ca2+ inside the
mitochondrial matrix was observed, causing partial dissipa-
tion of the inner membrane potential and O
•−
2 production
[51]. In addition to causing an endogenous increase of
O
•−
2 during contact of epimastigotes with human serum,4 Journal of Parasitology Research
this noninfective stage also triggers O
•−
2 formation by
macrophages, with high, almost lethal, toxicity to the cell
because of the formation of peroxynitrite [52–54]. On the
other hand, infective trypomastigotes may be less exposed
to peroxynitrite, as these forms may not stimulate the res-
piratory burst eﬃciently [54]. Nevertheless, internalization
of T. cruzi trypomastigotes by macrophages may activate
NADPH oxidase, which is involved in O
•−
2 production and
peroxynitrite formation. These forms also showed a higher
sensitivity to peroxynitrite than to H2O2 [37]. Conversely,
Tanaka et al. [55] demonstrated that H2O2 is the main
oxygen metabolite responsible for killing T. cruzi inside
macrophages, and T. cruzi trypomastigotes were shown
to be more resistant to killing by H2O2 than were the
epimastigotes. The LD50 at which epimastigotes were killed
was 6.0nmol/min/ml of H2O2, while the LD50 for try-
pomastigotes was 8.7nmol/min/ml of H2O2 in vitro [55].
Exposure of metacyclic trypomastigotes to 70μMH 2O2 for
6h caused an increase of 46-fold in G6PDH speciﬁc activity,
while G6PDH activity from epimastigote forms presented
a time-dependent decrease at the same conditions [56]. It
seems that trypomastigotes are more resistant to killing
by activated primary macrophages or by increased oxygen
radicals than epimastigotes [55]. Nevertheless, overexpres-
sion of epimastigote TcCPX increased parasite virulence and
resistance to macrophage killing [57]. In trypomastigotes,
the increased expression of antioxidant enzymes may also be
involved to the persistence of these forms in the serum
[41, 58, 59] or inside macrophages during phagocytosis. In
agreement with this thought, trypomastigotes with TcCPx
overexpressed, caused an increase in parasitemia and tissue
inﬂammation during mouse infections [37]. More severe
infections were also observed within metastatic forms of
Leishmania; this was suggested to be due to the functional
activity of peroxiredoxin [60]. Therefore T. cruzi antioxidant
defense could be considered an important virulence factor
[37, 57].
Although T. cruzi epimastigotes are shown to be more
sensitive to ROS, these cells can tolerate various levels of oxi-
dants. Pretreatment of T. cruzi epimastigotes with low H2O2
concentrations (15–20μM) allowed an increase in cell prolif-
eration of parasites, accompanied by a transient adaptation
response to higher H2O2 concentrations [35]. Moreover,
transient oxidative stress can also induce T. cruzi epimastig-
otes growth by heme stimulation via a mechanism mediated
by a CaM Kinase II-like pathway [61]. This adaptation
mechanismcouldberelatedtoincreasingexpressionlevelsof
arginine kinase, an enzyme involved in the interconversion
between phosphoarginine, a molecule with high energetic
potentiallikecreatine,andATP.Theprocesswassuggestedto
beindependentofredoxcontent,indicatingtheparticipation
of an unknown stress response mechanism [62].
4.Redox MetabolismandDrug Resistance
The drugs currently used against Chagas disease are nifur-
timox and benznidazole, two nitro chemotherapeutic agents
described to have trypanocidal eﬀects and an ability to
generate ROS. ROS generation may occur through the
reduction of the nitro group by the action of nitro anion
radical or hydronitroxide radical which then may react with
molecular oxygen generating O
•−
2 .[ 63, 64]. Susceptibility of
T.cruzitonifurtimoxandbenznidazolehasbeendescribedas
correlated with the levels of free and conjugated glutathione
[63, 65]. Treatment of T. cruzi cultures with nifurtimox or
benznidazole resulted in a loss of reduced thiol compounds
(GSH, trypanothione and glutathionyl spermidine), which
was suggested to be probably due to the conjugation of these
compounds with reduced metabolites of the nitro drugs
rather than an oxidation eﬀect on thiol consumption [65,
66]. Besides, it was also observed that redox-cycling activity
of nifurtimox was only acquired at high concentrations
doses (>400μM), two orders of magnitude higher than
that required for antiproliferative activity [66]. Moreover,
nifurtimox has been reported to act as an inhibitor of T.
cruzi trypanothione reductase, an enzyme responsible for
the maintenance of reduced state of the intracellular thiols
[67, 68]. The total amount of free or conjugated glutathione
may vary greatly either between diﬀerent strains of T. cruzi
or between the diﬀerent life stages of a unique strain, with
the following diﬀerentiation sequence: epimastigote > try-
pomastigote > amastigote [64]. These diﬀerences in thiol
contents could explain the diversity in resistance of T. cruzi
stages to treatment with these drugs and in its sensibility
to ROS. The resistance of T. cruzi to trypanocidal drugs
can also be associated with higher expression of enzymatic
antioxidants. In vitro-induced T. cruzi resistant to benznida-
zole presented an increase in the expression of the cytosolic
and mitochondrial tryparedoxin peroxidase isoforms and in
FeSOD isoforms, compared with the correspondent sensitive
lineage. [69–71]. Interestingly, these observations were not
involved in naturally resistant strains [69–71]. In T. brucei,
null mutants for SODB1 (cytosolic, glycosomal) exhibited
3-fold increased susceptibility to nifurtimox than wild-type
cells [72]. It seems that nifurtimox and benznidazole divert
thiol compounds from their ability to act as free radical
scavengers. Therefore the protection against the toxic eﬀects
of ROS might rely on enzymatic antioxidant activities.
Antioxidant defenses and drug susceptibility of most studied
T. cruzi strains are summarized in Table 1.
With respect to the search for alternative drugs for
Chagas disease, the activity of natural compounds such as
naphthoquinones, natural products of several families of
higher plants, has been extensively investigated [73]. Like
nifurtimox and benznidazole, the cytotoxicity of naphtho-
quinones has been implicated in redox cycling and ROS
generation [74]. Recently, three derivative compounds
of C-allyl lawsone (2-hydroxy-3-allyl-1,4-naphthoquinone)
were shown to be eﬀective against intracellular amastig-
otes, decreasing the percentage of infection in murine
macrophages, with low toxicity to host cells. Indeed, it seems
that this compound is involved in mitochondrial damage,
accompanied by an increase in H2O2 generation. Epimastig-
otes were shown to be more resistant than trypomastigotes
to treatment with these compounds, despite having a more
sensitive mitochondrion and higher accumulation of H2O2
within the cells [75]. Another type of naphthoquinone, anJournal of Parasitology Research 5
Table 1: Antioxidant defenses and drug susceptibility of T. cruzi strains.
Strain DTU∗ Redox state Drug
susceptibility Reference
YI I Low concentrations of antioxidant
enzymes; lower activity of G6PDH Resistant [42, 44]
Tulahuen VI
High concentrations of antioxidant
enzymes; higher activity of G6PDH;
lower Thiol contents
Susceptible [42, 44, 65]
Colombiana I
High concentrations of antioxidant
enzymes; no alteration of TcCPX and
TcMPX and FeSOD isoforms
Resistant (natural) [42, 69–71]
Cl Brener VI No alteration of TcCPX and TcMPX
and FeSOD isoforms
Susceptible (in
vitro) [69–71]
∗Discrete typing units (DTUs), according to Zingales et al., 2009 [43].
α-lapachone derivative, was shown to have a trypanocidal
eﬀect. This compound was tested against two strains of T.
cruzi, the Y strain (T. cruzi II) and the Colombian strain (T.
cruzi I), which presented higher resistance to the treatment
than Y. In line with these ﬁndings, the Y strain is partially
resistant and the Colombian strain is highly resistant to
the chemotherapeutic agents currently in use. In contrast
with the other naphthoquinones, this α-lapachone derivative
does not have the capacity to generate free radicals, instead,
it might function in the inhibition of proteinases [76].
Although sensibility to ROS may be related to the diﬀerent
T. cruzi groups, in vitro analysis of prooxidant drugs
susceptibility between T. cruzi Ia n dT. cruzi II strains showed
no signiﬁcant diﬀerences [45, 46]. However, correlation
between the susceptibility to benznidazole in distinct genetic
groups of T. cruzi has been described [77]. The subject is still
controversial, and in this case, geographic distribution and
phylogenetic distances of parasites must be considered [45].
5. Conclusions
T. cruzi epimastigotes present divergent behavior after expo-
sure to oxidative stress. It seems that these cells can deal with
external addition of H2O2, on the other hand, the generation
of ROS from mammalian sites like serum and the immune
system represents a challenge to these cells. For example,
membrane-boundphosphatasesfromT.cruziaremoreresis-
tant to the addition of sublethal doses of hydrogen peroxide
than Trypanosoma rangeli phosphatase [78]. Interestingly,
the concentrations of trypanothione vary between 1.52–
2.1mM in epimastigotes, 0.5mM in trypomastigotes, and
0.12mM in amastigotes [41]. At the same time, there is an
increase in the expression of antioxidant enzymes during
the diﬀerentiation of T. cruzi from a noninfective form to
the infective form, trypomastigotes [41, 58]. In contrast,
stress-inducedoxidantresistanceinLeishmaniachagasiisnot
accompanied by an increase in ROS scavengers, but instead
is suggested to be associated with heat shock proteins like
HSP70 [79, 80]. The mechanism by which T. cruzi escape
from the oxidative burst of mammalian macrophages is still
unknown; nevertheless, exposure of phosphatidylserine on
the surface of trypomastigotes surface induces a deactivating
eﬀect on macrophages. This proﬁle is also seen in apoptotic
cells as a means to avoid anti-inﬂammatory responses [67].
There is a growing interest in understanding how ROS
could be involved in the signaling process that permits par-
asites to colonize such diﬀerent microenvironments. In this
way, especially for T. cruzi, the extreme heterogeneity of this
population and its susceptibility to oxygen metabolites must
be carefully noted. These observations, in addition to their
epidemiological signiﬁcance, could permit the development
of more eﬀective drugs for the treatment of Chagas disease.
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